Loading…
Pak1 maintains epidermal stem cells by regulating Langerhans cells and is required for skin carcinogenesis
Pak1 (serine/threonine p21-activated kinases) was previously reported to have oncogenic activity in several cancers. However, its roles in the cancer microenvironment are poorly understood. We demonstrated that Pak1 expression in Langerhans cells (LCs) is essential for the maintenance of epidermal s...
Saved in:
Published in: | Oncogene 2020-06, Vol.39 (24), p.4756-4769 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Pak1
(serine/threonine p21-activated kinases) was previously reported to have oncogenic activity in several cancers. However, its roles in the cancer microenvironment are poorly understood. We demonstrated that
Pak1
expression in Langerhans cells (LCs) is essential for the maintenance of epidermal stem cells and skin tumor development. We found that PAK1 is localized in LCs by immunohistochemistry. Furthermore, the number of LCs significantly decreased in MSM/Ms
Pak1
homozygous knockout mice (MSM/Ms-
Pak1
-/-
). F
1
hybrid (FVB/NĂ—MSM/Ms)
Pak1
heterozygous knockout mice (F
1
-
Pak1
+/-
) had increased numbers of Th17 cells in the skin. Therefore,
Pak1
knockdown cells were prepared using LC-derived XS52 cells (XS52-
Pak1
KD) and co-cultured with keratinocyte-derived C5N cells. As a result, XS52-
Pak1
KD cell supernatants promoted C5N cell proliferation. We then carried out DMBA/TPA skin carcinogenesis experiments using F
1
-
Pak1
+/-
mice. Of note, F
1
-
Pak1
+/-
mice exhibited stronger resistance to skin tumors than control mice. F
1
-
Pak1
+/-
mice had fewer epidermal stem cells in the skin bulge. Our study suggested that
Pak1
regulates the epidermal stem cell number by changing the properties of LCs and functions in skin carcinogenesis. We clarified a novel role of
Pak1
in regulating LCs as a potential therapeutic target in skin immune disease and carcinogenesis. |
---|---|
ISSN: | 0950-9232 1476-5594 |
DOI: | 10.1038/s41388-020-1323-3 |